CD28 Antibody, anti-human, PE-Vio® 770 130-104-222 from Miltenyi Biotec | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
Miltenyi Biotec for
CD28 Antibody, anti-human, PE-Vio® 770

The CD28 Antibody, anti-human, PE-Vio® 770 from Miltenyi Biotec is a Mouse Monoclonal antibody to CD28. This antibody recognizes Human, and Non-Human Primate antigen. The CD28 Antibody, anti-human, PE-Vio® 770 has been validated for the following applications: Flow Cytometry.

Product Specs
ItemCD28 Antibody, anti-human, PE-Vio® 770
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-104-222
Quantity30 tests in 300 µL
ApplicationsFlow cytometry
Conjugate/TagPE-Vio 770
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
Reactivityhuman, non-human primate
TargetCD28
IsotypeIgG1
Clone15E8
Hostmouse
Antibody TypePrimary antibodies
NCBI Full Gene NameCD28 molecule
NCBI Gene AliasesTp44
Clonalitymonoclonal
Regulatory StatusFor research use only
Concentration1:11
Research AreaFor research use only

Add to Compare List

Miltenyi Biotec

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) CD28-mediated regulation of multiple myeloma cell proliferation and survivalBloodJune 1, 2007Bahlis NJ, King AM, Kolonias D, Carlson LM, Liu HY, Hussein MA, Terebelo HR, Byrne GE Jr, Levine BL, Boise LH, et al.

(2) Trapping and apoptosis of novel subsets of memory T lymphocytes expressing CCR6 in the spleen of HIV-infected patientsBloodMay 1, 2007Lécureuil C, Combadière B, Mazoyer E, Bonduelle O, Samri A, Autran B, Debré P, Combadière C.

(3) CD28 and CTLA-4 have opposing effects on the response of T cells to stimulationThe Journal of experimental medicineAugust 1, 1995Krummel MF, Allison JP.

(4) Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferationScience (New York, N.Y.)November 5, 1993Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VA Jr, Lombard LA, Gray GS, Nadler LM.

(5) The role of the CD28 receptor during T cell responses to antigenAnnual review of immunologyJanuary 1, 1993Linsley PS, Ledbetter JA.

(6) Role of the CD28 receptor in T-cell activationImmunology todayJune 1, 1990June CH, Ledbetter JA, Linsley PS, Thompson CB.

(7) Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cellsJournal of immunology (Baltimore, Md. : 1950)June 15, 1987Kozbor D, Moretta A, Messner HA, Moretta L, Croce CM.

Be the First to Write a Review!